DJIA 17,856.78 -278.94 -1.54%
NASDAQ 4,927.37 -55.44 -1.11%
S&P 500 2,071.26 -29.78 -1.42%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

6 Big Pharmaceutical Companies You Don't Want In Your Portfolio

Glaxo Submits Another Revolade Application in the EU - Analyst Blog

Theravance/Glaxo's Asthma Drug Under FDA Panel Review - Analyst Blog

Theravance/Glaxo's Asthma Drug Under FDA Panel Review - Analyst Blog

Theravance Biopharma: GSK Accelerates On High-Potential COPD Therapy

Theravance Biopharma: GSK Accelerates Study Of High-Potential COPD Therapy

Which Biotech Stock Should Pfizer, Inc. Buy?

Motley Fool contributors offer up three potential acquisition targets for Pfizer.

3 Blockbuster Drugs That May Be Obsolete in 5 Years

Motley Fool experts highlight three blockbuster-selling therapies that could fall by the wayside in the next five years.

GlaxoSmithKline (GSK) Downgraded From Buy to Hold

FTSE 100 in line for weekly rise; Shire shares slump

Pharmaceuticals Remain In The Spotlight - Cramer's Lightning Round (2/5/15)

See More Articles...